Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.5730
+0.0021 (0.37%)
At close: Apr 24, 2026, 4:00 PM EDT
0.5800
+0.0070 (1.22%)
After-hours: Apr 24, 2026, 7:59 PM EDT
Immutep Revenue
Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.79% growth. This brings the company's revenue in the last twelve months to 4.13M, up 7,650.57% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.
Revenue (ttm)
4.13M AUD
Revenue Growth
+7,650.57%
P/S Ratio
13.94
Revenue / Employee
133,292 AUD
Employees
31
Market Cap
73.66M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 59.71K | -59.38K | -49.86% |
| Jun 30, 2024 | 119.09K | -72.63K | -37.88% |
| Jun 30, 2023 | 191.72K | -62.67K | -24.63% |
| Jun 30, 2022 | 254.39K | -58.45K | -18.68% |
| Jun 30, 2021 | 312.84K | -7.45M | -95.97% |
| Jun 30, 2020 | 7.77M | 6.47M | 499.78% |
| Jun 30, 2019 | 1.29M | -2.34M | -64.42% |
| Jun 30, 2018 | 3.64M | 2.84M | 354.63% |
| Jun 30, 2017 | 800.46K | 625.41K | 357.27% |
| Jun 30, 2016 | 175.05K | - | - |
| Jun 30, 2015 | - | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | - | - | - |
| Jun 30, 2012 | - | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | - | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
| Jun 30, 2006 | - | - | - |
| Jun 30, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 63.26M |
| ImmuCell | 27.64M |
| Pelthos Therapeutics | 16.80M |
| TScan Therapeutics | 10.33M |
| aTyr Pharma | 190.00K |
IMMP News
- 1 day ago - Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP - PRNewsWire
- 2 days ago - ROSEN, LEADING INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP - Newsfile Corp
- 4 days ago - ROSEN, SKILLED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP - Newsfile Corp
- 4 days ago - IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 4 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP - GlobeNewsWire
- 6 days ago - ROSEN, A TOP RANKED LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP - Newsfile Corp
- 6 days ago - Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP - PRNewsWire
- 7 days ago - IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire